Patent 9101539 was granted and assigned to Shin Nippon Biomedical Laboratories on August, 2015 by the United States Patent and Trademark Office.
Methods are provided for the engineering of inhalable dry powder pharmaceutical formulations with desired pharmacokinetic profiles and parameters. Compositions with improved pharmacokinetics are disclosed.